Symptomatic Hemorrhage From Cerebral Cavernous Malformations: Evidence from a Cohort Study.
Sign Up to like & getrecommendations! Published in 2019 at "World neurosurgery"
DOI: 10.1016/j.wneu.2019.12.035
Abstract: OBJECTIVES Patients with a cerebral cavernous malformation (CCM) can suffer from intracranial hemorrhages ranging from insignificant and chronic microbleeds to life-threatening hemorrhage. Current management decisions and patient counseling are based on a heterogeneous body of… read more here.
Keywords: symptomatic hemorrhage; evidence; hemorrhage; cohort ... See more keywords
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH)
Sign Up to like & getrecommendations! Published in 2019 at "Neurosurgery"
DOI: 10.1093/neuros/nyy108
Abstract: BACKGROUND Brain cavernous angiomas with symptomatic hemorrhage (CASH) are uncommon but exact a heavy burden of neurological disability from recurrent bleeding, for which there is no proven therapy. Candidate drugs to stabilize the CASH lesion… read more here.
Keywords: angiomas symptomatic; cash; symptomatic hemorrhage; hemorrhage ... See more keywords
Abstract 121: Prospective Symptomatic Hemorrhage Rates And Functional Outcomes In Trial Eligible Cavernous Angiomas With Symptomatic Hemorrhage
Sign Up to like & getrecommendations! Published in 2023 at "Stroke"
DOI: 10.1161/str.54.suppl_1.121
Abstract: Background: Cerebral cavernous angiomas with symptomatic hemorrhage (CASH) carry highest rebleed rates and are targeted for novel interventions. A multisite clinical trial readiness project (clinicaltrials.gov NCT03652181) aims to identify clinical and functional changes over time… read more here.
Keywords: angiomas symptomatic; hemorrhage; cavernous angiomas; symptomatic hemorrhage ... See more keywords